PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Oct-2025 Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane Parasail - ResearchAndMarkets.com Businesswire
06-Oct-2025 Iron Overload Syndrome Market Report 2025-2035: Epidemiology, Overview and Ecosystem, Regulations, Competitive Landscape, Pipeline Analysis - ResearchAndMarkets.com Businesswire
06-Oct-2025 Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine... Businesswire
06-Oct-2025 CD47 Inhibitors Drug Market Clinical Trials Insight 2026 | 80+ CD47 Inhibitor Drugs Currently in Clinical Trials - ResearchAndMarkets.com Businesswire
06-Oct-2025 Kerecis to Showcase Medical Fish Skin for Reconstructive Surgery at Plastic Surgery The Meeting 2025 Businesswire
06-Oct-2025 EyeCare Partners to Showcase Optometric Expertise and Innovation at the American Academy of Optometry (AAO) Academy 2025 Boston Businesswire
06-Oct-2025 Empowering Brands with Bio-Based Innovation: Braskem Highlights I'm green™ bio-based Portfolio at Sustainable Brands Businesswire
06-Oct-2025 Top Government Lawyers Chart New Path in Private Practice at Scale LLP Businesswire
06-Oct-2025 GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings Businesswire
06-Oct-2025 Vaccine Manufacturing GMP (Good Manufacturing Practice) Principles in Training Course (Dec 10th - Dec 11th, 2025) - ResearchAndMarkets.com Businesswire
06-Oct-2025 BrightSpec Names Rick Gordon as CEO Businesswire
06-Oct-2025 A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Online Training Course (Nov 4, 2025) - ResearchAndMarkets.com Businesswire
06-Oct-2025 Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth Businesswire
06-Oct-2025 Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies Businesswire
06-Oct-2025 GordonMD Global Investments® Backs Star Therapeutics in $125 Million Series D Financing Businesswire
06-Oct-2025 I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance Businesswire
06-Oct-2025 API Innovation Center Report Spotlights Cross-Sector Dialogue on Drug Shortages Businesswire
06-Oct-2025 Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies Businesswire
06-Oct-2025 Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event Businesswire
06-Oct-2025 TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III Businesswire